- Home
- AMS vs MTNB Comparison
AMS vs MTNB Comparison
Compare AMS & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- MTNB
- Stock Information
- Founded
- AMS 1980
- MTNB 2013
- Country
- AMS United States
- MTNB United States
- Employees
- AMS N/A
- MTNB N/A
- Industry
- AMS Medical Specialities
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- AMS Health Care
- MTNB Health Care
- Exchange
- AMS Nasdaq
- MTNB Nasdaq
- Market Cap
- AMS 19.5M
- MTNB 16.1M
- IPO Year
- AMS N/A
- MTNB N/A
- Fundamental
- Price
- AMS $3.09
- MTNB $0.63
- Analyst Decision
- AMS
- MTNB Hold
- Analyst Count
- AMS 0
- MTNB 1
- Target Price
- AMS N/A
- MTNB N/A
- AVG Volume (30 Days)
- AMS 19.9K
- MTNB 562.9K
- Earning Date
- AMS 11-13-2024
- MTNB 11-13-2024
- Dividend Yield
- AMS N/A
- MTNB N/A
- EPS Growth
- AMS 566.31
- MTNB N/A
- EPS
- AMS 0.66
- MTNB N/A
- Revenue
- AMS $23,104,000.00
- MTNB N/A
- Revenue This Year
- AMS $29.39
- MTNB N/A
- Revenue Next Year
- AMS $16.22
- MTNB N/A
- P/E Ratio
- AMS $4.30
- MTNB N/A
- Revenue Growth
- AMS 13.49
- MTNB N/A
- 52 Week Low
- AMS $2.32
- MTNB $0.50
- 52 Week High
- AMS $4.60
- MTNB $21.50
- Technical
- Relative Strength Index (RSI)
- AMS 47.64
- MTNB 23.27
- Support Level
- AMS $2.85
- MTNB $0.50
- Resistance Level
- AMS $3.24
- MTNB $0.79
- Average True Range (ATR)
- AMS 0.14
- MTNB 0.27
- MACD
- AMS -0.02
- MTNB -0.01
- Stochastic Oscillator
- AMS 58.54
- MTNB 4.56
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.